The level of the COVID-19 vaccine uptake in African countries and especially Nigeria is still considerably low, when compared with other developed countries, despite the established fact on its efficacy in protecting the populace from the negative consequences of the disease. This research investigated the knowledge and attitudes of students at Ondo State College of Health Technology regarding the COVID-19 vaccine. Adopting a descriptive survey design, the study targeted Technician students from six departments, with 300 participants selected via random sampling. Data were gathered using a semi-structured questionnaire, “Trainee Health Workers Knowledge and Attitude Questionnaire,” addressing four research questions and seven hypotheses. Frequency counts, percentages, and charts were used for analysis, while Chi Square was used to test hypotheses at a 0.05 significance level. Findings revealed a high acceptance rate of the COVID-19 vaccine among students, though fewer had taken the second and booster doses. Participants demonstrated high knowledge and positive attitudes toward the vaccine, with low levels of misconceptions. Gender and age did not significantly influence students' knowledge or attitudes. However, the course of study significantly affected their knowledge and attitudes toward the vaccine. Additionally, there was a significant relationship between knowledge and attitude, indicating that knowledge does not necessarily equate to willingness to accept the vaccine. Recommendations included increasing exposure to valid information about the COVID-19 vaccine and conducting college-wide sensitization campaigns to persuade unvaccinated students by emphasizing the vaccine's importance. These efforts should particularly target those with remaining misconceptions.
Published in | European Journal of Preventive Medicine (Volume 12, Issue 3) |
DOI | 10.11648/j.ejpm.20241203.12 |
Page(s) | 70-80 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Students, Knowledge of COVID-19, Attitude Towards COVID-19
Characteristics (N=300) | Frequency | Percentage |
---|---|---|
Gender | ||
Male | 63 | 21.0% |
Female | 237 | 79.0% |
Age groups (years) | ||
25 and Above | 68 | 22.7 |
Below 25 | 232 | 77.3 |
Marital status | ||
Married | 9 | 3.0% |
Single | 291 | 97.0% |
Department | ||
Community Health Extension Workers | 58 | 19.3% |
Dental Health Technician | 35 | 11.7% |
Environmental Health | 50 | 16.7% |
Health Information Management | 82 | 27.3% |
Medical Laboratory Technician | 41 | 13.7% |
Pharmacy Technician | 34 | 11.3% |
Source of COVID-19 Vaccine information. | ||
Internet | 139 | 46.3% |
Social media | 153 | 51% |
Electronic Media (Radio/TV) | 117 | 39% |
College Sensitisation/Lecturers | 144 | 48% |
Family and Friends | 126 | 42% |
Frequency | Percent | Valid Percent | Cumulative Percent | ||
---|---|---|---|---|---|
Valid | No | 78 | 26.0 | 26.0 | 26.0 |
Yes | 222 | 74.0 | 74.0 | 100.0 | |
Total | 300 | 100.0 | 100.0 |
Frequency | Percent | Valid Percent | Cumulative Percent | ||
---|---|---|---|---|---|
Valid | 78 | 26.0 | 26.0 | 26.0 | |
First and Second dose | 93 | 31.0 | 31.0 | 57.0 | |
First dose only | 109 | 36.3 | 36.3 | 93.3 | |
First, Second and Booster dose | 20 | 6.7 | 6.7 | 100.0 | |
Total | 300 | 100.0 | 100.0 |
SN | ITEM | YES | N/S | NO |
---|---|---|---|---|
1 | COVID-19 Vaccine is a serious disease. | 284 (94.7%) | 13 4.3% | 3 (1.0%) |
2 | Mortality rate of COVID-19 vaccine is over 6 million. | 182 (60.7%) | 112 (37.3) | 6 (2.0%) |
3 | There exist vaccine for COVID-19. | 261 (87.0%) | 27 (9.0) | 12 (4.0) |
4 | COVID-19 Vaccine is very safe | 254 (84.7%) | 41 (13.7%) | 5 (1.7%) |
5 | The vaccine can prevent and cure COVID-19 infection. | 224 (74.7%) | 63 (21.0%) | 13 (4.3%) |
6 | Not all health workers are expected to take the jabs, it depends on the unit one works. | 65 (21.7%) | 77 (25.7%) | 158 (52.7%) |
7 | I believe COVID-19 Vaccine will help stop the pandemic | 258 (86.0%) | 32 (10.7%) | 10 (3.3) |
8 | COVID-19 vaccines could worsen pre-existing health conditions | 117 (39.0%) | 79 26.3%) | 104 (34.7) |
9 | I know that Corona virus infection can be prevented with a vaccine | 259 (86.3%) | 33 (11.0%) | 8 (2.7%) |
10 | I am aware that COVID-19 vaccine is available free of charge. | 280 (93.3%) | 14 (4.7%0 | 6 (2.0%) |
11 | I know that aware that the COVID-19 vaccine should be taken in two doses, then booster dose follows. | 254 (84.7%) | 33 (11.0%) | 13 (4.3%) |
12 | COVID-19 vaccine may cause mild side effects | 184 (61.3%) | 79 (26.3%) | 37 (12.3% |
13 | COVID-19 vaccine is not recommended for people less than 18 years of age and pregnant women | 200 (66.7%) | 68 (22.7%) | 32 (10.7) |
SN | ITEM | YES | NOT SURE | NO |
---|---|---|---|---|
1 | It is important to take COVID-19 Vaccine. | 281 (93.7) | 17 (5.7) | 2 (0.7) |
2 | Taking COVID-19 vaccine is for my own good. | 281 (93.7) | 17 (5.7) | 2 (0.7) |
3 | There is no need to take the COVID-19 vaccine at all. | 22 (7.3) | 53 (17.7) | 225 (75.0) |
4 | COVID-19 vaccines are not safe. | 31 (1.0.3) | 65 (21.7) | 204 (68.0) |
5 | COVID-19 Vaccines were hurriedly prepared; hence it is not to be trusted. | 47 (15.7) | 91 (30.3) | 162 (54.0) |
6 | It is not possible to reduce and control the incidence of covid-19 with vaccination. | 68 (22.7) | 72 (24.0) | 160 (53.3) |
7 | I am not scared of COVID-19 vaccine but I am not just interested. | 89 (29.7) | 35 (11.7) | 176 (58.7) |
8 | I feel that the COVID-19 vaccine must be taken by all that are eligible to take it. | 254 (84.7) | 23 (7.7) | 23 (7.7) |
9 | I believe that the COVID-19 vaccine should be prioritized for a specific population | 147 (49.0) | 57 (19.0) | 96 (32.0) |
10 | COVID-19 vaccine provide good protection after a few weeks against coronavirus infection. | 201 (67.0) | 62 (20.7) | 37 (12.3) |
11 | I will freely discuss the benefit of COVID-19 vaccine with people around me. | 257 (85.7) | 28 (9.3) | 15 (5.0) |
12 | I am disturbed that getting the vaccine could lead to infection. | 61 (20.3) | 54 (18.0) | 185 (61.7) |
SN | ITEM | YES | NOT SURE | NO |
---|---|---|---|---|
1 | COVID-19 is not real, it’s a matter of conspiracy. | 30 (10.0) | 49 (16.3) | 221 (73.7) |
2 | Blacks cannot be infected by COVID-19. | 24 (8.0) | 57 (19.0) | 219 (73.0) |
3 | COVID-19 is a punishment from God, and nothing can stop it. | 14 (4.7) | 68 (22.7) | 218 (72.7) |
4 | COVID-19 is a plot to reduce the world population. | 49 (16.3) | 81 (27.0) | 170 (56.7) |
5 | The side effects of COVID-19 vaccine outweigh the positive impact. | 85 (28.3) | 77 (25.7) | 138 (46.0) |
6 | The vaccines are not efficacious as been presented. | 71 (23.7) | 93 (31.0) | 136 (45.3) |
7 | COVID_19 vaccine can lead to severe allergic reactions in most people that take it. | 147 (49.0) | 68 (22.7) | 85 (28.3) |
8 | It can lead to infertility or birth defect in future. | 34 (11.3) | 99 (33.0) | 167 (55.7) |
9 | The vaccine contains undisclosed controversial substances that can affect my health. | 53 (17.7) | 103 (34.3) | 144 (48.0) |
10 | Local herbs can fight virus generally than any vaccine. | 47 (15.7) | 96 (32.0) | 157 (52.3) |
Value | Df | Asymptotic Significance (2-sided) | Exact Sig. (2-sided) | Exact Sig. (1-sided) | |
---|---|---|---|---|---|
Pearson Chi-Square | 2.112a | 1 | .146 | ||
Continuity Correctionb | 1.513 | 1 | .219 | ||
Likelihood Ratio | 2.378 | 1 | .123 | ||
Fisher's Exact Test | .183 | .105 | |||
N of Valid Cases | 300 |
Value | Df | Asymptotic Significance (2-sided) | Exact Sig. (2-sided) | Exact Sig. (1-sided) | |
---|---|---|---|---|---|
Pearson Chi-Square | .000a | 1 | .991 | ||
Continuity Correctionb | .000 | 1 | 1.000 | ||
Likelihood Ratio | .000 | 1 | .991 | ||
Fisher's Exact Test | 1.000 | .559 | |||
N of Valid Cases | 300 |
Value | Df | Asymptotic Significance (2-sided) | Exact Sig. (2-sided) | Exact Sig. (1-sided) | |
---|---|---|---|---|---|
Pearson Chi-Square | 1.899a | 1 | .168 | ||
Continuity Correctionb | 1.445 | 1 | .229 | ||
Likelihood Ratio | 2.026 | 1 | .155 | ||
Fisher's Exact Test | .218 | .113 | |||
N of Valid Cases | 300 |
Value | df | Asymptotic Significance (2-sided) | |
---|---|---|---|
Pearson Chi-Square | 19.736a | 5 | .001 |
Likelihood Ratio | 21.009 | 5 | .001 |
N of Valid Cases | 300 |
Value | Df | Asymptotic Significance (2-sided) | Exact Sig. (2-sided) | Exact Sig. (1-sided) | |
---|---|---|---|---|---|
Pearson Chi-Square | 72.992a | 1 | .000 | ||
Continuity Correctionb | 68.975 | 1 | .000 | ||
Likelihood Ratio | 55.750 | 1 | .000 | ||
Fisher's Exact Test | .000 | .000 | |||
N of Valid Cases | 300 |
COVID-19 | Corona Virus Disease- 2019 |
SARS-CoV-2 | Severe Acute Respiratory Syndrome Coronavirus |
THWCVKAQ | Trainee Health Workers’ COVID-19 Vaccine Knowledge and Attitude Questionnaire |
[1] | Africa CDC. (2021). COVID-19 Dashboard. Retrieved from |
[2] | WHO. (2021). COVAX Global Initiative for COVID-19 Vaccine Equity. Retrieved from |
[3] |
Nigeria Centre for Disease Control. (2020). First Case of Coronavirus Disease Confirmed in Nigeria. Retrieved from
https://ncdc.gov.ng/news/227/first-case-of-corona-virus-disease-confirmed-in-nigeria |
[4] | Anjorin, A. A.; Odetokun, I. A.; Abioye, A. I., Elnadi, H.; Umoren, M. V.; Damaris, B. F., et al. (2021). Will Africans take COVID-19 vaccination? PLoS ONE 16(12): e0260575. |
[5] | Jatau, A. I., Wada, A. S., Bala, A. M., et al. (2021). Vaccine Hesitancy Amongst Medical and Paramedical Students in Nigeria. African Journal of Health Sciences, 22(3), 57-63. |
[6] | Gerend, M. A. & Shepherd, J. E. (2012) Predicting human papillomavirus vaccine uptake in young adult women: comparing the health belief model and theory of planned behavior. Ann Behav Med; 44(2): 171–180. |
[7] | Phillips, N. (2021. The coronavirus is here to stay-here’s what that means. Nature; 590 (7846): 382–384. |
[8] | Moddassir, A., Loai, K. B. M.; Mohammad, T. A. & Mahdi, J. (2022). Public Attitude Towards COVID-19 Vaccination: Validation of COVID-Vaccination Attitude Scale (C-VAS). Journal of Multidisciplinary Healthcare, 2022: 15, 941–954. |
[9] |
WHO. (2019). Ten threats to global health in 2019. World Health Organization.
https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019 |
[10] | IFRC. (2020). COVID-19: Rapport sur les retours d’information de la communaute´.#7. Dakar: 2020 13 May, 2020. Report No: Contract No.: 7. |
[11] | Ovenseri-Ogbomo, G.; Ishaya, T.; Osuagwu, U. L.; Abu, E. K.; Nwaeze, O.; Oloruntoba, R.; et al (2020). Factors associated with the myth about 5G network during COVID-19 pandemic in sub-Saharan Africa. Journal of Global Health Reports. |
[12] |
Aiyewumi O, Okeke MI. (2020). The myth that Nigerians are immune to SARS-CoV-2 and that COVID-19 is a hoax are putting lives at risk. J Glob Health. 2020 Dec; 10(2): 020375.
https://doi.org/10.7189/jogh.10.020375 PMID: 33110566; PMCID: PMC7568914. |
[13] | British Broadcasting Corporation (BBC). Coronavirus: What misinformation has spread in Africa? 2020 (updated 2020 April 24, February 17, 2021). |
[14] | Syan, S. K.; Gohari, M. R.; Levitt, E. E.; Belisario, K.; Gillard, J.; DeJesus, J. & MacKillop, J. (2021) COVID-19 Vaccine Perceptions and Differences by Sex, Age, and Education in 1,367 Community Adults in Ontario. Front. Public Health 9: 719665. |
[15] |
WHO. (2022). COVID-19 Weekly Epidemiological Update. Retrieved from
https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---22-june-2022 |
[16] | WHO. (2022). COVID-19 Dashboard. World Health Organization. |
[17] | Leela, P., et al. (2021). High Acceptance Rate of COVID-19 Vaccine Among Medical Students in Kerala. Journal of Medical Sciences. |
[18] | Li, L., Cheng, Y., Tao, C., Chen, H., & Zeng, X. (2022). Knowledge and Attitudes Towards COVID-19 Vaccine Among Geriatric Care Facility Staff in Anhui Province, China. Journal of Geriatric Studies. |
[19] | Bono, S. A., Faria de Moura Villela, E., Siau, C. S., Chen, W. S., Pengpid, S., Hasan, M. T.,... & Dube, E. (2021). Factors Affecting COVID-19 Vaccine Acceptance: An International Survey Among Low- and Middle-Income Countries. Vaccines, 9(5), 515. |
[20] | Syan, S. K., Gohar, B., Munoz-Baena, A., Motz, T., & Lavis, J. N. (2021). Age Differences in COVID-19 Knowledge and Misconceptions Among Ontario Residents. Canadian Journal of Public Health, 112(3), 396-403. |
[21] | Yoda, T., & Katsuyama, H. (2021). Willingness to Receive COVID-19 Vaccination in Japan. Vaccines, 9(1), 48. |
[22] | Barello, S., Nania, T., Dellafiore, F., Graffigna, G., & Caruso, R. (2020). ‘Vaccine Hesitancy’ among University Students in Italy during the COVID-19 Pandemic. European Journal of Epidemiology, 35(8), 781-783. |
APA Style
Daniel, E. O., Olawale, O. O., Bello, A. M., Tomori, M. O., Avwerhota, M., et al. (2024). Knowledge and Attitude Towards COVID-19 Vaccine: A Cross-Sectional Study of Students at a Tertiary Educational Institution in Nigeria. European Journal of Preventive Medicine, 12(3), 70-80. https://doi.org/10.11648/j.ejpm.20241203.12
ACS Style
Daniel, E. O.; Olawale, O. O.; Bello, A. M.; Tomori, M. O.; Avwerhota, M., et al. Knowledge and Attitude Towards COVID-19 Vaccine: A Cross-Sectional Study of Students at a Tertiary Educational Institution in Nigeria. Eur. J. Prev. Med. 2024, 12(3), 70-80. doi: 10.11648/j.ejpm.20241203.12
AMA Style
Daniel EO, Olawale OO, Bello AM, Tomori MO, Avwerhota M, et al. Knowledge and Attitude Towards COVID-19 Vaccine: A Cross-Sectional Study of Students at a Tertiary Educational Institution in Nigeria. Eur J Prev Med. 2024;12(3):70-80. doi: 10.11648/j.ejpm.20241203.12
@article{10.11648/j.ejpm.20241203.12, author = {Ebenezer Obi Daniel and Oluseyi Oludamilola Olawale and Ahmed Mamuda Bello and Michael Olabode Tomori and Michael Avwerhota and Israel Olukayode Popoola and Adebanke Adetutu Ogun and Taiwo Aderemi Popoola and Aisha Oluwakemi Salami and Olukayode Oladeji Alewi and Celestine Emeka Ekwuluo}, title = {Knowledge and Attitude Towards COVID-19 Vaccine: A Cross-Sectional Study of Students at a Tertiary Educational Institution in Nigeria }, journal = {European Journal of Preventive Medicine}, volume = {12}, number = {3}, pages = {70-80}, doi = {10.11648/j.ejpm.20241203.12}, url = {https://doi.org/10.11648/j.ejpm.20241203.12}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ejpm.20241203.12}, abstract = {The level of the COVID-19 vaccine uptake in African countries and especially Nigeria is still considerably low, when compared with other developed countries, despite the established fact on its efficacy in protecting the populace from the negative consequences of the disease. This research investigated the knowledge and attitudes of students at Ondo State College of Health Technology regarding the COVID-19 vaccine. Adopting a descriptive survey design, the study targeted Technician students from six departments, with 300 participants selected via random sampling. Data were gathered using a semi-structured questionnaire, “Trainee Health Workers Knowledge and Attitude Questionnaire,” addressing four research questions and seven hypotheses. Frequency counts, percentages, and charts were used for analysis, while Chi Square was used to test hypotheses at a 0.05 significance level. Findings revealed a high acceptance rate of the COVID-19 vaccine among students, though fewer had taken the second and booster doses. Participants demonstrated high knowledge and positive attitudes toward the vaccine, with low levels of misconceptions. Gender and age did not significantly influence students' knowledge or attitudes. However, the course of study significantly affected their knowledge and attitudes toward the vaccine. Additionally, there was a significant relationship between knowledge and attitude, indicating that knowledge does not necessarily equate to willingness to accept the vaccine. Recommendations included increasing exposure to valid information about the COVID-19 vaccine and conducting college-wide sensitization campaigns to persuade unvaccinated students by emphasizing the vaccine's importance. These efforts should particularly target those with remaining misconceptions. }, year = {2024} }
TY - JOUR T1 - Knowledge and Attitude Towards COVID-19 Vaccine: A Cross-Sectional Study of Students at a Tertiary Educational Institution in Nigeria AU - Ebenezer Obi Daniel AU - Oluseyi Oludamilola Olawale AU - Ahmed Mamuda Bello AU - Michael Olabode Tomori AU - Michael Avwerhota AU - Israel Olukayode Popoola AU - Adebanke Adetutu Ogun AU - Taiwo Aderemi Popoola AU - Aisha Oluwakemi Salami AU - Olukayode Oladeji Alewi AU - Celestine Emeka Ekwuluo Y1 - 2024/06/26 PY - 2024 N1 - https://doi.org/10.11648/j.ejpm.20241203.12 DO - 10.11648/j.ejpm.20241203.12 T2 - European Journal of Preventive Medicine JF - European Journal of Preventive Medicine JO - European Journal of Preventive Medicine SP - 70 EP - 80 PB - Science Publishing Group SN - 2330-8230 UR - https://doi.org/10.11648/j.ejpm.20241203.12 AB - The level of the COVID-19 vaccine uptake in African countries and especially Nigeria is still considerably low, when compared with other developed countries, despite the established fact on its efficacy in protecting the populace from the negative consequences of the disease. This research investigated the knowledge and attitudes of students at Ondo State College of Health Technology regarding the COVID-19 vaccine. Adopting a descriptive survey design, the study targeted Technician students from six departments, with 300 participants selected via random sampling. Data were gathered using a semi-structured questionnaire, “Trainee Health Workers Knowledge and Attitude Questionnaire,” addressing four research questions and seven hypotheses. Frequency counts, percentages, and charts were used for analysis, while Chi Square was used to test hypotheses at a 0.05 significance level. Findings revealed a high acceptance rate of the COVID-19 vaccine among students, though fewer had taken the second and booster doses. Participants demonstrated high knowledge and positive attitudes toward the vaccine, with low levels of misconceptions. Gender and age did not significantly influence students' knowledge or attitudes. However, the course of study significantly affected their knowledge and attitudes toward the vaccine. Additionally, there was a significant relationship between knowledge and attitude, indicating that knowledge does not necessarily equate to willingness to accept the vaccine. Recommendations included increasing exposure to valid information about the COVID-19 vaccine and conducting college-wide sensitization campaigns to persuade unvaccinated students by emphasizing the vaccine's importance. These efforts should particularly target those with remaining misconceptions. VL - 12 IS - 3 ER -